Becoming Without: Making Transgenic Mosquitoes and Disease Control in Brazil
By Luísa Reis-Castro,
Duke University Press
| 11. 01. 2021
The First Bite
At the end of a day of fieldwork in Juazeiro, a city in Northeast Brazil, I sat in bed trying to write up my notes. A noisy fan in my small room was not alleviating the suffocating heat, so I moved to the porch to breath in some fresh air. Not long after I sat down, an itch on my left arm prompted a quick swat from my right hand. I turned my hand over to see a dead mosquito, with blood smeared on my skin. During my stay in Juazeiro, in the semiarid region of the Bahia state, mosquitoes, which in this region are broadly called muriçocas, were a constant presence. The itchiness caused by their bites is a nuisance, but they can also be dangerous: some mosquitoes convey disease pathogens. As I inspected the dead mosquito that afternoon my trained eye recognized its black-and-white stripes as a telltale signature of the Aedes aegypti, a species notorious for transmitting viruses such as dengue, chikungunya, Zika, and (urban) yellow fever.
It was the A. aegypti...
Related Articles
By Sarojini Nadimpally and Gargi Mishra, The Wire | 12.15.2024
In-vitro fertilisation (IVF) as assisted reproductive technology (ART) has been in vogue for quite a few decades now. While IVF has been hailed as a significant scientific advancement, with many advantages, here are some limitations which bear keeping in mind...
Image by Mohamed Hassan from Pixabay
It is hard to make predictions, especially about the future, as Yogi Berra, Niels Bohr, and other luminaries have remarked. But there are already signs that the incoming Trump administration may have some difficulty establishing consistent policies about controversial issues concerning human reproduction.
On the one hand, consider “the conservative blueprint for a second Trump administration.”
The notorious Project 2025’s Mandate for Leadership seeks to delete terms such as “reproductive rights” from “every federal...
By Susan Dominus, The New York Times | 11.30.2024
In the days after Daphna Cardinale delivered her second child, she experienced a rare sense of calm and wonder. The feeling was a relief after so much worrying: She and her husband, Alexander, had tried for three years to conceive...
By Christy Santhosh, Reuters | 11.27.2024
Nov 27 (Reuters) - The U.S. Food and Drug Administration is weighing the need for regulatory action on bluebird bio's (BLUE.O), opens new tab gene therapy for a rare neurological disorder, it said on Wednesday, as the agency probes additional...